Engineering and Development

Management and Executive

Chairman and CEO

EVP, Chief Commercial Officer

Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market

Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands

Vor Bio appoints Osovsky as General Counsel

Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel

Medical Science Liaison (MSL) Rheumatology

Vor Biopharma is on a mission to redefine the future of autoimmune care by advancing innovative therapies. The Medical Science Liaison (MSL) in Rheumatology will serve as a scientific expert, fostering partnerships with healthcare professionals and supporting the development of telitacicept for Sjogren’s Disease.

Medical Science Liaison (MSL) Rheumatology – West

Chief People Officer

Sign up with Google

Sign in with Google